EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Ceftolozane/Tazobactam Susceptibility in ESBL-Producing Enterobacterales: Insights from the SMART Program 2020–2022 in China

Yanfei Wang, Yuke Zhang, Jingjing Quan, Ying Fu, Zhihui Zhou, Jiaqi Xia, Yunsong Yu

Infection and Drug Resistance · 2026-09 · Volume 19 · 1-12

DOI: 10.2147/idr.s624172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Drug Resistance, 2026-09. Verfasst von Yanfei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, People's Republic …. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ESBL‑producing EnterobacteralesSMARTceftolozane/tazobactamdrug resistance

Autor:innen und Institutionen

  • Department of Infectious Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, People's Republic of China.
  • Department of Clinical Laboratory, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, People's Republic of China.
  • Value & Implementation, MSD China, Shanghai, 200030, People's Republic of China.
  • Zhejiang Provincial Engineering Research Center of Innovative Instruments for Precise Pathogen Detection, Hangzhou, Zhejiang, 310016, People's Republic of China.

Zitieren

APA

Wang, Y., Zhang, Y., Quan, J., Fu, Y., Zhou, Z., Xia, J., & Yu, Y. (2026). Ceftolozane/Tazobactam Susceptibility in ESBL-Producing Enterobacterales: Insights from the SMART Program 2020–2022 in China. Infection and Drug Resistance, Volume 19, 1-12. https://doi.org/10.2147/idr.s624172

Vancouver

Wang Y, Zhang Y, Quan J, Fu Y, Zhou Z, Xia J, et al. Ceftolozane/Tazobactam Susceptibility in ESBL-Producing Enterobacterales: Insights from the SMART Program 2020–2022 in China. Infection and Drug Resistance. 2026;Volume 19:1-12. doi:10.2147/idr.s624172

BibTeX
@article{Wang2026,
  author = {Wang, Yanfei and Zhang, Yuke and Quan, Jingjing and Fu, Ying and Zhou, Zhihui and Xia, Jiaqi and Yu, Yunsong},
  title = {Ceftolozane/Tazobactam Susceptibility in ESBL-Producing Enterobacterales: Insights from the SMART Program 2020–2022 in China},
  journal = {Infection and Drug Resistance},
  year = {2026},
  volume = {Volume 19},
  pages = {1--12},
  doi = {10.2147/idr.s624172}
}
Kostenlos starten →